Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 22, 2012

 

 

MERCK & CO., INC.

(Exact name of registrant as specified in its charter)

 

 

 

New Jersey

(State or other jurisdiction

of incorporation or organization)

 

1-6571

(Commission file number)

 

22-1918501

(I.R.S. Employer

Identification No.)

One Merck Drive, P.O. Box 100,

Whitehouse Station, NJ

(Address of principal executive offices)

 

 

08889

(Zip code)

Registrant’s telephone number, including area code: (908) 423-1000

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

The following matters were voted upon at the Annual Meeting of Shareholders held on May 22, 2012, and received the votes set forth below:

 

1. All of the following persons nominated were elected to serve as directors and received the number of votes set forth opposite their respective names:

 

Names

     For        Against        Abstained        Broker Non-Votes  

Leslie A. Brun

       2,163,943,500           40,442,629           4,080,348           369,671,037   

Thomas R. Cech

       2,170,163,508           34,365,185           3,937,784           369,671,037   

Kenneth C. Frazier

       2,150,116,889           53,951,726           4,397,862           369,671,037   

Thomas H. Glocer

       2,192,615,614           11,843,107           4,007,756           369,671,037   

William B. Harrison, Jr.

       2,185,796,945           18,047,594           4,621,938           369,671,037   

C. Robert Kidder

       2,171,051,222           32,755,388           4,660,867           369,671,037   

Rochelle B. Lazarus

       2,194,068,848           10,406,063           3,991,566           369,671,037   

Carlos E. Represas

       2,171,905,615           32,408,575           4,152,287           369,671,037   

Patricia F. Russo

       2,176,761,695           27,830,097           3,874,685           369,671,037   

Craig B. Thompson

       2,194,093,018           9,817,512           4,555,947           369,671,037   

Wendell P. Weeks

       2,194,773,154           9,716,365           3,976,958           369,671,037   

Peter C. Wendell

       2,191,095,017           13,339,539           4,031,921           369,671,037   

 

2. A proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2012 received 2,511,085,763 votes FOR and 60,687,574 votes AGAINST, with 6,364,177 abstentions.

 

3. A proposal to approve, by a non-binding advisory vote, executive compensation of our Named Executive Officers received 2,131,911,470 votes FOR and 61,776,173 votes AGAINST, with 14,778,834 abstentions and 369,671,037 broker non-votes.

 

4. A shareholder proposal concerning shareholder action by written consent received 998,693,065 votes FOR and 1,196,955,887 votes AGAINST, with 12,817,525 abstentions and 369,671,037 broker non-votes.

 

5. A shareholder proposal concerning special shareholder meetings received 749,829,658 votes FOR and 1,447,703,621 votes AGAINST, with 10,933,198 abstentions and 369,671,037 broker non-votes.

 

6. A shareholder proposal concerning a report on charitable and political contributions received 83,412,002 votes FOR and 1,978,268,642 votes AGAINST, with 146,785,834 abstentions and 369,671,036 broker non-votes.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 25, 2012

 

Merck & Co., Inc.
By:   /s/ Katie E. Fedosz
  Name:    Katie E. Fedosz
  Title:   Senior Assistant Secretary